Phathom Pharmaceuticals to Report Third Quarter 2026 Financial Results and Provide Business Update on Thursday, October 29, 2026
Globe Newswire•19/10/2026•08:00 ET
0
Key Highlights
- ➤Phathom will report Q3 2026 financial results on October 29, 2026
- ➤Live webcast begins at 8:00 am EDT on October 29, 2026
- ➤Phathom markets VOQUEZNA for GERD and H. pylori infection in the U.S.
FLORHAM PARK, N.J., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) diseases, today announced that it will host a live webcast at 8:00 am EDT on Thursday, October 29, 2026, to report its third quarter 2026 financial results and provide a business update.
A live webcast and additional information about the presentation can be accessed on the Events & Presentations section of the Phathom website at https://investors.phathompharma.com/news-events/events-and-presentations. A recording will be available for 90 days following the conclusion of the call.
Get started
Create a free account to read the full story.